Loading
H2 Receptor Antagonist·Gastrointestinal - Acid Suppression
Treatment of gastric and duodenal ulcers, GORD, Zollinger-Ellison syndrome
Max Dose
80 mg/day
Half-life
3 h
CYP Inhibitor
NONE
Renal Adj.
DOSE RED.
Overview
Histamine H2 receptor antagonist. Highly effective acid-suppressor. Unlike its predecessor (Cimetidine), it has zero dangerous liver enzyme interactions, making it incredibly safe for polypharmacy.
Maximum Dose
Max 80 mg/day (e.g., 40 mg BD).
Clinical Focus
Predominantly renally cleared. Must halve the dose in severe kidney failure to prevent toxic CNS accumulation (delirium/seizures).
Bottom Line
Famotidine is an H2 receptor antagonist for acid suppression with fewer drug interactions than PPIs, but is less potent than PPIs and tolerance develops with regular use.
Brand Names
Pepzan, Pamacid
Oral Routes
Tablets (20 mg, 40 mg).
Parenteral
Ampoules (20 mg/2 mL) for IV use.
Prescribing & PBS
Unrestricted General Benefit (S4 for 40mg/IV). OTC (S2) for 20mg.
Primary
Treatment of gastric and duodenal ulcers, GORD, Zollinger-Ellison syndrome.
Off-Label
Refractory chronic urticaria (hives), adjunct in anaphylaxis protocols.
Clinical Place
Step-down therapy from PPIs. The preferred H2 antagonist worldwide after Ranitidine was recalled due to NDMA contamination.